A phase 2b prospective, randomised, global multi-arm study evaluating ALTB-268 (high and low) with placebo in patients with moderately to severely active UC

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 29 Oct 2024

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

28 Oct 2024 According to an AltruBio media release, this trial is planned to be initiated in first half of 2025.
21 May 2024 According to an AltruBio media release, trial planned to be initiated later in 2024.
21 May 2024 According to an AltruBio media release, study is anticipated to read out in 2H of 2026.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com